4. Medication Adherence Interventions: Comparative Effectiveness: Closing the Quality Gap: Revisiting the State of the Science (Evidence Report/Technology Assessment Number 208)

0 avg rating
( 0 ratings by Goodreads )
 
9781483935157: 4. Medication Adherence Interventions: Comparative Effectiveness: Closing the Quality Gap: Revisiting the State of the Science (Evidence Report/Technology Assessment Number 208)

Achieving the goal of quantitatively improving the quality and effectiveness of health care for all Americans requires both knowledge and tools. Although medical researchers have demonstrated many efficacious medical treatments to improve health outcomes, a recent Institute of Medicine report identified a disquieting discrepancy between present treatment success rates and those thought to be achievable. This gap has been attributed partly to barriers that providers face in implementing best practice guidelines. Patients’ adherence to treatment, however, provides an additional explanation for the incongruity between recommended treatment and actual treatment outcomes. Poor medication adherence is relatively common. Studies have shown consistently that 20 to 30 percent of medication prescriptions are never filled and that, on average, 50 percent of medications for chronic disease are not taken as prescribed. This lack of adherence to medications is not only prevalent, but also has dramatic effects on individual and population-level health. Nonadherence has been estimated to cost the U.S. health care system between $100 billion and $289 billion annually in direct costs. Strong evidence suggests that benefits attributable to improved self-management of chronic diseases could result in a cost-to-savings ratio of approximately 1:10. Medication adherence is defined as “the extent to which patients take medication as prescribed by their health care providers.” Medication adherence refers to the patient’s conformance with the provider’s recommendation with respect to timing, dosage, and frequency of medication taking during the prescribed length of time. In contrast, persistence refers to the act of continuing the treatment for the prescribed duration and may be defined as the total length of time a patient takes a medication, demarcated by the time between first and last dose. Health outcomes may be improved by helping patients better adhere to and persist with recommended treatment, in much the same sense that such outcomes may be improved by enhancing provider implementation of best practice guidelines. This review seeks to synthesize evidence regarding the efficacy and effectiveness of interventions to improve medication adherence among adults across a broad array of chronic conditions. This report is part of a larger initiative, the Closing the Quality Gap: Revisiting the State of the Science series. This series continues to summarize evidence on means to improve quality of care, but it focuses on selected settings, interventions, and clinical conditions. Our report addresses the comparative effectiveness of adherence intervention strategies, one keystone to improving the gap between potential and realized quality health care. The five Key Questions (KQs) that are the focus of this review are: KQ 1: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of interventions aimed at patients, providers, systems, and combinations of audiences in improving medication adherence? b. Is improved medication adherence associated with improvement in patient outcomes? KQ 2: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of policy interventions in improving medication adherence? b. Is improved medication adherence associated with improvement in patient outcomes? KQ 3: a. How do medication-adherence intervention characteristics (e.g., mode of delivery, intervention target, intensity) vary? b. To what extent do the effects of adherence interventions vary based upon their characteristics? KQ 4: To what extent do the effects of adherence interventions vary based on differences in vulnerable populations? KQ 5: What unintended consequences are associated with interventions to improve medication adherence?

"synopsis" may belong to another edition of this title.

Buy New View Book
List Price: US$ 44.99
US$ 48.53

Convert Currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

U S Department of Heal Human Services, Agency for Healthcare Resea And Quality
Published by Createspace Independent Publishing Platform, United States (2013)
ISBN 10: 1483935159 ISBN 13: 9781483935157
New Paperback Quantity Available: 10
Print on Demand
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Createspace Independent Publishing Platform, United States, 2013. Paperback. Book Condition: New. Language: English . Brand New Book ***** Print on Demand *****.Achieving the goal of quantitatively improving the quality and effectiveness of health care for all Americans requires both knowledge and tools. Although medical researchers have demonstrated many efficacious medical treatments to improve health outcomes, a recent Institute of Medicine report identified a disquieting discrepancy between present treatment success rates and those thought to be achievable. This gap has been attributed partly to barriers that providers face in implementing best practice guidelines. Patients adherence to treatment, however, provides an additional explanation for the incongruity between recommended treatment and actual treatment outcomes. Poor medication adherence is relatively common. Studies have shown consistently that 20 to 30 percent of medication prescriptions are never filled and that, on average, 50 percent of medications for chronic disease are not taken as prescribed. This lack of adherence to medications is not only prevalent, but also has dramatic effects on individual and population-level health. Nonadherence has been estimated to cost the U.S. health care system between $100 billion and $289 billion annually in direct costs. Strong evidence suggests that benefits attributable to improved self-management of chronic diseases could result in a cost-to-savings ratio of approximately 1:10. Medication adherence is defined as the extent to which patients take medication as prescribed by their health care providers. Medication adherence refers to the patient s conformance with the provider s recommendation with respect to timing, dosage, and frequency of medication taking during the prescribed length of time. In contrast, persistence refers to the act of continuing the treatment for the prescribed duration and may be defined as the total length of time a patient takes a medication, demarcated by the time between first and last dose. Health outcomes may be improved by helping patients better adhere to and persist with recommended treatment, in much the same sense that such outcomes may be improved by enhancing provider implementation of best practice guidelines. This review seeks to synthesize evidence regarding the efficacy and effectiveness of interventions to improve medication adherence among adults across a broad array of chronic conditions. This report is part of a larger initiative, the Closing the Quality Gap: Revisiting the State of the Science series. This series continues to summarize evidence on means to improve quality of care, but it focuses on selected settings, interventions, and clinical conditions. Our report addresses the comparative effectiveness of adherence intervention strategies, one keystone to improving the gap between potential and realized quality health care. The five Key Questions (KQs) that are the focus of this review are: KQ 1: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of interventions aimed at patients, providers, systems, and combinations of audiences in improving medication adherence? b. Is improved medication adherence associated with improvement in patient outcomes? KQ 2: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of policy interventions in improving medication adherence? b. Is improved medication adherence associated with improvement in patient outcomes? KQ 3: a. How do medication-adherence intervention characteristics (e.g., mode of delivery, intervention target, intensity) vary? b. To what extent do the effects of adherence interventions vary based upon their characteristics? KQ 4: To what extent do the effects of adherence interventions vary based on differences in vulnerable populations? KQ 5: What unintended consequences are associated with interventions to improve medication adherence?. Bookseller Inventory # APC9781483935157

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 48.53
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

U S Department of Heal Human Services, Agency for Healthcare Resea And Quality
Published by Createspace Independent Publishing Platform, United States (2013)
ISBN 10: 1483935159 ISBN 13: 9781483935157
New Paperback Quantity Available: 10
Print on Demand
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Createspace Independent Publishing Platform, United States, 2013. Paperback. Book Condition: New. Language: English . Brand New Book ***** Print on Demand *****. Achieving the goal of quantitatively improving the quality and effectiveness of health care for all Americans requires both knowledge and tools. Although medical researchers have demonstrated many efficacious medical treatments to improve health outcomes, a recent Institute of Medicine report identified a disquieting discrepancy between present treatment success rates and those thought to be achievable. This gap has been attributed partly to barriers that providers face in implementing best practice guidelines. Patients adherence to treatment, however, provides an additional explanation for the incongruity between recommended treatment and actual treatment outcomes. Poor medication adherence is relatively common. Studies have shown consistently that 20 to 30 percent of medication prescriptions are never filled and that, on average, 50 percent of medications for chronic disease are not taken as prescribed. This lack of adherence to medications is not only prevalent, but also has dramatic effects on individual and population-level health. Nonadherence has been estimated to cost the U.S. health care system between $100 billion and $289 billion annually in direct costs. Strong evidence suggests that benefits attributable to improved self-management of chronic diseases could result in a cost-to-savings ratio of approximately 1:10. Medication adherence is defined as the extent to which patients take medication as prescribed by their health care providers. Medication adherence refers to the patient s conformance with the provider s recommendation with respect to timing, dosage, and frequency of medication taking during the prescribed length of time. In contrast, persistence refers to the act of continuing the treatment for the prescribed duration and may be defined as the total length of time a patient takes a medication, demarcated by the time between first and last dose. Health outcomes may be improved by helping patients better adhere to and persist with recommended treatment, in much the same sense that such outcomes may be improved by enhancing provider implementation of best practice guidelines. This review seeks to synthesize evidence regarding the efficacy and effectiveness of interventions to improve medication adherence among adults across a broad array of chronic conditions. This report is part of a larger initiative, the Closing the Quality Gap: Revisiting the State of the Science series. This series continues to summarize evidence on means to improve quality of care, but it focuses on selected settings, interventions, and clinical conditions. Our report addresses the comparative effectiveness of adherence intervention strategies, one keystone to improving the gap between potential and realized quality health care. The five Key Questions (KQs) that are the focus of this review are: KQ 1: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of interventions aimed at patients, providers, systems, and combinations of audiences in improving medication adherence? b. Is improved medication adherence associated with improvement in patient outcomes? KQ 2: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of policy interventions in improving medication adherence? b. Is improved medication adherence associated with improvement in patient outcomes? KQ 3: a. How do medication-adherence intervention characteristics (e.g., mode of delivery, intervention target, intensity) vary? b. To what extent do the effects of adherence interventions vary based upon their characteristics? KQ 4: To what extent do the effects of adherence interventions vary based on differences in vulnerable populations? KQ 5: What unintended consequences are associated with interventions to improve medication adherence?. Bookseller Inventory # APC9781483935157

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 51.94
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Human Services, U. S. Department of Heal
ISBN 10: 1483935159 ISBN 13: 9781483935157
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description 2013. PAP. Book Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9781483935157

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 47.96
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

4.

Human Services, U. S. Department of Heal
ISBN 10: 1483935159 ISBN 13: 9781483935157
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description 2013. PAP. Book Condition: New. New Book. Delivered from our UK warehouse in 3 to 5 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9781483935157

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 43.29
Convert Currency

Add to Basket

Shipping: US$ 11.88
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Human Services, U. S. Department of Health and; and Quality, Agency for Healthcare Research
Published by CreateSpace Independent Publishing Platform
ISBN 10: 1483935159 ISBN 13: 9781483935157
New PAPERBACK Quantity Available: > 20
Seller:
Russell Books
(Victoria, BC, Canada)
Rating
[?]

Book Description CreateSpace Independent Publishing Platform. PAPERBACK. Book Condition: New. 1483935159 Special order direct from the distributor. Bookseller Inventory # ING9781483935157

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 50.61
Convert Currency

Add to Basket

Shipping: US$ 7.00
From Canada to U.S.A.
Destination, Rates & Speeds

6.

U. S. Department of Health and Human Services
Published by Createspace
ISBN 10: 1483935159 ISBN 13: 9781483935157
New Paperback Quantity Available: > 20
Print on Demand
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description Createspace. Paperback. Book Condition: New. This item is printed on demand. Paperback. 690 pages. Dimensions: 9.2in. x 7.5in. x 1.6in.Achieving the goal of quantitatively improving the quality and effectiveness of health care for all Americans requires both knowledge and tools. Although medical researchers have demonstrated many efficacious medical treatments to improve health outcomes, a recent Institute of Medicine report identified a disquieting discrepancy between present treatment success rates and those thought to be achievable. This gap has been attributed partly to barriers that providers face in implementing best practice guidelines. Patients adherence to treatment, however, provides an additional explanation for the incongruity between recommended treatment and actual treatment outcomes. Poor medication adherence is relatively common. Studies have shown consistently that 20 to 30 percent of medication prescriptions are never filled and that, on average, 50 percent of medications for chronic disease are not taken as prescribed. This lack of adherence to medications is not only prevalent, but also has dramatic effects on individual and population-level health. Nonadherence has been estimated to cost the U. S. health care system between 100 billion and 289 billion annually in direct costs. Strong evidence suggests that benefits attributable to improved self-management of chronic diseases could result in a cost-to-savings ratio of approximately 1: 10. Medication adherence is defined as the extent to which patients take medication as prescribed by their health care providers. Medication adherence refers to the patients conformance with the providers recommendation with respect to timing, dosage, and frequency of medication taking during the prescribed length of time. In contrast, persistence refers to the act of continuing the treatment for the prescribed duration and may be defined as the total length of time a patient takes a medication, demarcated by the time between first and last dose. Health outcomes may be improved by helping patients better adhere to and persist with recommended treatment, in much the same sense that such outcomes may be improved by enhancing provider implementation of best practice guidelines. This review seeks to synthesize evidence regarding the efficacy and effectiveness of interventions to improve medication adherence among adults across a broad array of chronic conditions. This report is part of a larger initiative, the Closing the Quality Gap: Revisiting the State of the Science series. This series continues to summarize evidence on means to improve quality of care, but it focuses on selected settings, interventions, and clinical conditions. Our report addresses the comparative effectiveness of adherence intervention strategies, one keystone to improving the gap between potential and realized quality health care. The five Key Questions (KQs) that are the focus of this review are: KQ 1: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of interventions aimed at patients, providers, systems, and combinations of audiences in improving medication adherence b. Is improved medication adherence associated with improvement in patient outcomes KQ 2: a. Among patients with chronic diseases with self-administered medication prescribed by a provider, what is the comparative effectiveness of policy interventions in improving medication adherence b. Is improved medication adherence associated with improvement in patient outcomes KQ 3: a. How do medication-adherence intervention characteristics (e. g. , mode of delivery, intervention target, intensity) vary b. To what extent do the effects of adherence interventions vary based upon their characteristics KQ 4: To what extent do the effects of adherence interventions vary based on differences in vulnerable populations KQ 5: What unintended consequences are associated with i This item ships from La Vergne,TN. Paperback. Bookseller Inventory # 9781483935157

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 66.68
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds